NIT
MRNS

NumerixS Investment Technologies’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

NumerixS Investment Technologies’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-14,625
Closed -$207K – 1403
2018
Q1 		$207K Buy
14,625
+12,875
+736% +$307K 0.05% 396
2017
Q4 		$57K Buy
+1,750
New +$47.2K 0.01% 826

Other funds holding MRNS

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

NumerixS Investment Technologies's MRNS Position: Q2 2018 in Review

NumerixS Investment Technologies sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2018, closing a stake of 14,625 shares — an estimated $207K sold.

NumerixS Investment Technologies first reported a position in MRNS in Q4 2017 and held it in 2 quarters. The position peaked at $207K in Q1 2018. 73 funds tracked by Wall St. Rank hold MRNS as of Q2 2018.

  • NumerixS Investment Technologies reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2018 after selling out during the quarter.
  • NumerixS Investment Technologies sold 14,625 Marinus Pharmaceuticals, Inc shares in Q2 2018, an estimated $207K.
  • NumerixS Investment Technologies first reported a position in Marinus Pharmaceuticals, Inc in Q4 2017 and held it in 2 quarters.
  • NumerixS Investment Technologies's Marinus Pharmaceuticals, Inc position peaked at $207K in Q1 2018.
  • 73 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2018.

Based on NumerixS Investment Technologies's 13F filing for Q2 2018, filed 10 Aug 2018.